Category: Replacement Heart Valves
JenaValve Technology adds nearly $11 million to its Series C round, taking the total to more than $73 million as it pursues the U.S. market with its transcatheter aortic valve implant.
UPDATED Nov. 18, 2014, with a clarification from JenaValve.
JenaValve Technology yesterday reported adding nearly $17.3 million to a Series C funding round, bring the total raise to nearly $79.8 million.
QT Vascular acquires the Java technology for aortic valvuloplasty in transcatheter aortic valve implants for an undisclosed amount.
QT Vascular said it acquired a new technology platform created by an undisclosed developer in Israel called Java that it plans to develop as an aortic valvuloplasty balloon for transcatheter aortic valve implants.
Medtronic launches a clinical trial to study a new replacement heart valve designed to be surgically implanted in patients with severe aortic stenosis.
Medtronic (NYSE:MDT) today said it launched a clinical trial for a new replacement heart valve designed for patients with severe narrowing of the aortic valve.
Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.
Medtronic reports positive data from a study evaluating an alternative implantation procedure for its CoreValve aortic valve-replacement device.
An FDA advisory panel recommends that CryoLife's heart valve, the CryoValve allograft, be subject to its most-stringent pre-market approval protocol.
Sorin announces the first U.S. implant of its recently approved Solo Smart aortic heart valve.
Sorin Group (BIT:SRN) said that a patient in Indianapolis was the first U.S. recipient of its recently approved Solo Smart aortic heart valve.